Anti-CCDC50 monoclonal antibody

Pre-made anti-CCDC50 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CCDC50/CCDC50 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2870-Ab-1/ GM-Tg-hg-IP2870-Ab-2Anti-Human CCDC50 monoclonal antibodyHuman
GM-Tg-rg-IP2870-Ab-1/ GM-Tg-rg-IP2870-Ab-2Anti-Rat CCDC50 monoclonal antibodyRat
GM-Tg-mg-IP2870-Ab-1/ GM-Tg-mg-IP2870-Ab-2Anti-Mouse CCDC50 monoclonal antibodyMouse
GM-Tg-cynog-IP2870-Ab-1/ GM-Tg-cynog-IP2870-Ab-2Anti-Cynomolgus/ Rhesus macaque CCDC50 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2870-Ab-1/ GM-Tg-felg-IP2870-Ab-2Anti-Feline CCDC50 monoclonal antibodyFeline
GM-Tg-cang-IP2870-Ab-1/ GM-Tg-cang-IP2870-Ab-2Anti-Canine CCDC50 monoclonal antibodyCanine
GM-Tg-bovg-IP2870-Ab-1/ GM-Tg-bovg-IP2870-Ab-2Anti-Bovine CCDC50 monoclonal antibodyBovine
GM-Tg-equg-IP2870-Ab-1/ GM-Tg-equg-IP2870-Ab-2Anti-Equine CCDC50 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2870-Ab-1/ GM-Tg-hg-IP2870-Ab-2; GM-Tg-rg-IP2870-Ab-1/ GM-Tg-rg-IP2870-Ab-2;
GM-Tg-mg-IP2870-Ab-1/ GM-Tg-mg-IP2870-Ab-2; GM-Tg-cynog-IP2870-Ab-1/ GM-Tg-cynog-IP2870-Ab-2;
GM-Tg-felg-IP2870-Ab-1/ GM-Tg-felg-IP2870-Ab-2; GM-Tg-cang-IP2870-Ab-1/ GM-Tg-cang-IP2870-Ab-2;
GM-Tg-bovg-IP2870-Ab-1/ GM-Tg-bovg-IP2870-Ab-2; GM-Tg-equg-IP2870-Ab-1/ GM-Tg-equg-IP2870-Ab-2
Products NameAnti-CCDC50 monoclonal antibody
Formatmab
Target NameCCDC50
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CCDC50 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2870-Ag-1Recombinant multi-species CCD50/ CCDC50/ C3orf6 protein


    Target information

    Target IDGM-IP2870
    Target NameCCDC50
    Gene ID152137,67501,288022,705459,478675,101080475,529404,100068861
    Gene Symbol and SynonymsC3orf6,C3orf6h,CCDC50,DFNA44,YMER
    Uniprot AccessionQ8IVM0,Q810U0
    Uniprot Entry NameCCD50_HUMAN,CCD50_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000152492
    Target ClassificationN/A

    The target: CCDC50, gene name: CCDC50, also named as C3orf6, DFNA44, YMER. This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.